|
|
|
 |
Ò©µê¹ú±ð£º |
|
| ²úµØ¹ú¼Ò£º | ÈÕ±¾ |
| ´¦ ·½ Ò©£º | ÊÇ |
| ËùÊôÀà±ð£º | 75ºÁ¿Ë/75ºÁ¿Ë/Ƭ 100Ƭ/ºÐ |
| °ü×°¹æ¸ñ£º |
75ºÁ¿Ë/75ºÁ¿Ë/Ƭ 100Ƭ/ºÐ |
| ¼Æ¼Ûµ¥Î»£º |
ºÐ |
| Éú²ú³§¼ÒÖÐÎIJο¼ÒëÃû: |
| Ìï±ßÈýÁâÖÆÒ© |
| Éú²ú³§¼ÒÓ¢ÎÄÃû: |
| Mitsubishi Tanabe Pharma Corporation |
| ¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·1: |
| https://www.info.pmda.go.jp/go/pack/3229102F1107_1_04/ |
| ¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·2: |
|
| ¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·3: |
|
|
| Ô²úµØÓ¢ÎÄÉÌÆ·Ãû: |
| ASPARA(¥¢¥¹¥Ñ¥éÅäºÏåV)100Tablets |
| Ô²úµØÓ¢ÎÄÒ©Æ·Ãû: |
| Potassium L-Aspartate/Magnesium L-Aspartate |
| ÖÐÎIJο¼ÉÌÆ·ÒëÃû: |
| ASPARA(¥¢¥¹¥Ñ¥éÅäºÏåV)100Ƭ/ºÐ |
| ÖÐÎIJο¼Ò©Æ·ÒëÃû: |
| L-ÌìÃŶ¬°±Ëá¼Ø/¶¬°±Ëáþ |
| ÔøÓÃÃû: |
|
|
|